June 22 2023 at 08:04PM FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy

FDA Approves Elevidys, a gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing reason why they cannot receive this therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SXoN8nL